SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
Crossref DOI link: https://doi.org/10.2337/dc16-0041
Published Online: 2016-04-14
Published Print: 2016-05-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Abdul-Ghani, Muhammad
Del Prato, Stefano
Chilton, Robert
DeFronzo, Ralph A.